Biodesix Reaches Agreement to Deliver Next-Generation Sequencing Assay for Blood-Based Companion Diagnostic Solutions in Cancer
10 July 2019
Biodesix, Inc, the leader in blood-based lung cancer diagnostic solutions, today announced it has entered into an agreement with Thermo Fisher Scientific. The agreement is designed to bring a blood
